Data / Crowdfunding / Arizona / iMetabolic Biopharma Corporation
iMetabolic Biopharma Corporation: crowdfunding raise on StartEngine Capital, LLC, $10,000 to $1,230,000 (2023)
iMetabolic Biopharma Corporation, a corporation in Phoenix, AZ, filed a Form C with the SEC on April 24, 2023 to raise $10,000 to $1,230,000 in Convertible Note through StartEngine Capital, LLC. The offering closed on July 6, 2023. In its most recent fiscal year it reported $137,329 in revenue and a net loss of $99,746, with 4 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- imbiopharma.com
- Funding portal
- StartEngine Capital, LLC
- Address
- 275 N Gateway Dr, Suite 104, Phoenix, AZ 85034
- Legal form
- Corporation
- Jurisdiction
- NV
- Incorporated
- November 17, 2017
- SEC CIK
- 0001957114
Offering terms
From the amendment filed April 24, 2023.
- Security
- Convertible Note
- Target
- $10,000
- Maximum
- $1,230,000
- Deadline
- July 6, 2023
- Portal compensation
- Up to 9% percent
Financials
From the Form C-AR filed May 6, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $137,329 | $129,520 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-99,746 | $-120,292 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $27,787 | $82,459 | sec.gov |
| Cash | $25,726 | $82,459 | sec.gov |
| Accounts receivable | $2 | $0 | sec.gov |
| Short-term debt | $65,378 | $47,853 | sec.gov |
| Long-term debt | $557,779 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| May 6, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| July 19, 2024 | Annual report | Not listed | Not listed | sec.gov | ||
| July 10, 2023 | Progress update | $10,000 | $1,230,000 | July 6, 2023 | At the close of the offering, the issuer closed on $342,505.18. | sec.gov |
| April 27, 2023 | Annual report | Not listed | Not listed | sec.gov | ||
| April 24, 2023 | Amendment | $10,000 | $1,230,000 | July 6, 2023 | Issuer is extending their end date and updating their financials | sec.gov |
| March 15, 2023 | Amendment | $10,000 | $1,230,000 | April 30, 2023 | Extending their end date | sec.gov |
| December 28, 2022 | Amendment | $10,000 | $1,230,000 | March 16, 2023 | Correction to perks | sec.gov |
| December 16, 2022 | Offering | $10,000 | $1,230,000 | March 16, 2023 | sec.gov |
Updated May 6, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.